Continuation of Research and Development Activities
First written in FY2017-Q1. 27 of 33 entries say "Restated". Latest entry: FY2026.
45 other companies' latest entry also says "Other".
- FY2026Production has started on the new large axle line; the start date for the roll-forming machine has changedAnnual report
「We are currently preparing for mass production and plan to begin production in August 2026.","The new large axle line using these process techniques and know-how was installed at the Fujisawa Plant, and production began in May 2026.」
While the new large axle line moved forward to a production start in May 2026, the planned production start for the roll-forming machine changed from June 2026 to August 2026. - 2026-05-15RestatedEarnings
「Based on the medium-term management plan covering fiscal 2024 through fiscal 2028, the Group has steadily pursued sales expansion, value-added growth and productivity improvements through growth investments, rationalization initiatives and other measures, producing results.」
The Company continued its growth investments, productivity improvements and rationalization initiatives under the medium-term plan. - FY2026-H1RestatedAnnual report
「Group-wide R&D expenses for the interim consolidated accounting period amounted to ¥144 million. There were no material changes in the status of the Group's R&D activities during the interim consolidated accounting period.」
The disclosure continues to state that there have been no material changes in R&D activities. R&D expenses amounted to ¥144 million. - FY2025Production start timing pushed backAnnual report
「We are currently preparing for mass production and plan to begin production in June 2026.","We are installing a new large axle line at the Fujisawa Plant using these process techniques and know-how, and plan to begin production in October 2025.」
R&D and production engineering initiatives are continuing, but the planned production start dates have changed from those previously indicated to June 2026 for the roll-forming machine and October 2025 for the new large axle line. - FY2025-H1RestatedAnnual report
「The group's total R&D expenses for the current interim consolidated accounting period were ¥310 million. There were no material changes in the status of the group's R&D activities during the current interim consolidated accounting period.」
The disclosure continues to state that there have been no material changes in R&D activities, and R&D expenses amounted to ¥310 million. - FY2024AdvancedAnnual report
「The company newly introduced a roll-forming machine for production of its core product, frames, enabling small-lot production while controlling tooling costs. Preparations for mass production are currently under way, with production scheduled to begin in February 2026."The company is proceeding with installation of a new large axle line at the Fujisawa Plant using the expertise from these methods, with production scheduled to begin in August 2025.」
R&D and production engineering have progressed to the concrete stages of introducing a roll-forming machine and preparing for mass production, and installing a new large axle line, with production scheduled to begin in February 2026 and August 2025, respectively. - FY2024-Q3RestatedAnnual report
「The group's total R&D expenses for the first nine months of the current consolidated cumulative period were ¥247 million. There were no material changes in the status of the group's R&D activities during the first nine months of the current consolidated cumulative period.」
The company continues to state that there were no material changes in the status of its R&D activities. R&D expenses were ¥247 million. - FY2024-Q2RestatedAnnual report
「The group's total R&D expenses for the first half of the current consolidated cumulative period were ¥163 million. There were no material changes in the status of the group's R&D activities during the first half of the current consolidated cumulative period.」
The company continues to state that there were no material changes in the status of its R&D activities. R&D expenses were ¥163 million. - FY2024-Q1RestatedAnnual report
「The group's total R&D expenses for the first quarter of the current consolidated cumulative period were ¥89 million. There were no material changes in the status of the group's R&D activities during the first quarter of the current consolidated cumulative period.」
The company continues to state that there were no material changes in its R&D activities. R&D expenses were ¥89 million. - FY2023AdvancedAnnual report
「After establishing these methods as mass-production processes in Japan, the company plans to expand them to new lines at overseas facilities as automation methods for welding-type frames produced there, with mass production scheduled to begin in June 2023.」
Following the establishment in Japan of the R&D results involving sensing, welding-quality stabilization and automated inspection as mass-production processes, the company plans to deploy them on new lines at overseas facilities and begin mass production in June 2023. - FY2023-Q3RestatedAnnual report
「The group's total R&D expenses for the first nine months of the current consolidated cumulative period were ¥264 million. There were no material changes in the status of the group's R&D activities during the first nine months of the current consolidated cumulative period.」
The company continues to state that there were no material changes in its R&D activities. R&D expenses were ¥264 million. - FY2023-Q2RestatedAnnual report
「The group's total R&D expenses for the first half of the current consolidated cumulative period were ¥148 million. There were no material changes in the status of the group's R&D activities during the first half of the current consolidated cumulative period.」
The company continues to state that there were no material changes in its R&D activities, and R&D expenses were ¥148 million. - FY2023-Q1RestatedAnnual report
「The group's total R&D expenses for the first quarter of the current consolidated cumulative period were ¥78 million. There were no material changes in the status of the group's R&D activities during the first quarter of the current consolidated cumulative period.」
The company reaffirmed that there were no material changes in the status of its R&D activities. R&D expenses were ¥78 million. - FY2022-Q3RestatedAnnual report
「The group's total R&D expenses for the first nine months of the current consolidated cumulative period were ¥289 million. There were no material changes in the status of the group's R&D activities during the first nine months of the current consolidated cumulative period.」
The company continues to state that there were no material changes in its R&D activities, and R&D expenses were ¥289 million. - FY2022-Q2RestatedAnnual report
「There were no material changes in the status of the group's R&D activities during the first half of the current consolidated cumulative period.」
The company continues to state that there were no material changes in its R&D activities. R&D expenses were ¥129 million. - FY2022-Q1RestatedAnnual report
「The group's total R&D expenses for the first quarter of the current consolidated cumulative period were ¥62 million. There were no material changes in the status of the group's R&D activities during the first quarter of the current consolidated cumulative period.」
The company continues to state that there were no material changes in its R&D activities, and R&D expenses were ¥62 million. - FY2021-Q2RestatedAnnual report
「The group's total R&D expenses for the first half of the current consolidated cumulative period were ¥90 million. There were no material changes in the status of the group's R&D activities during the first half of the current consolidated cumulative period.」
The company continues to state that there were no material changes in the status of its R&D activities, and R&D expenses were ¥90 million. - FY2021-Q1RestatedAnnual report
「The group's total R&D expenses for the first quarter of the current consolidated cumulative period were ¥46 million. There were no material changes in the status of the group's R&D activities during the first quarter of the current consolidated cumulative period.」
The company continues to state that there were no material changes in its R&D activities. R&D expenses were ¥46 million. - FY2020AdvancedAnnual report
「These methods have been adopted for the new medium-sized axle line scheduled to begin mass production at the Fujisawa Plant in September 2020.」
The R&D activities disclosure described specific progress involving the adoption of sensing, welding-quality stabilization and automated inspection methods for the new medium-sized axle line, with mass production scheduled to begin in September 2020. - FY2020-Q3RestatedAnnual report
「The group's total R&D expenses for the first nine months of the current consolidated cumulative period were ¥200 million. There were no material changes in the status of the group's R&D activities during the first nine months of the current consolidated cumulative period.」
The company continues to state that there were no material changes in its R&D activities. R&D expenses were ¥200 million. - FY2020-Q2RestatedAnnual report
「The group's total R&D expenses for the first half of the current consolidated cumulative period were ¥117 million. There were no material changes in the status of the group's R&D activities during the first half of the current consolidated cumulative period.」
The company continues to state that there were no material changes in its R&D activities. R&D expenses were ¥117 million. - FY2020-Q1RestatedAnnual report
「The group's total R&D expenses for the first quarter of the current consolidated cumulative period were ¥42 million. There were no material changes in the status of the group's R&D activities during the first quarter of the current consolidated cumulative period.」
The company continues to state that there were no material changes in its R&D activities. - FY2019-Q3RestatedAnnual report
「The group's total R&D expenses for the first nine months of the current consolidated cumulative period were ¥269 million. There were no material changes in the status of the group's R&D activities during the first nine months of the current consolidated cumulative period.」
The company continues to state that there were no material changes in its R&D activities, and R&D expenses were ¥269 million. - FY2019-Q2RestatedAnnual report
「The group's total R&D expenses for the first half of the current consolidated cumulative period were ¥187 million. There were no material changes in the status of the group's R&D activities during the first half of the current consolidated cumulative period.」
The company continues to state that there were no material changes in its R&D activities. R&D expenses were ¥187 million. - FY2019-Q1RestatedAnnual report
「The group's total R&D expenses for the first quarter of the current consolidated cumulative period were ¥46 million. There were no material changes in the status of the group's R&D activities during the first quarter of the current consolidated cumulative period.」
The company continues to state that there were no material changes in its R&D activities. R&D expenses were ¥46 million. - FY2018RestatedAnnual report
「During the fiscal year, the company pursued the realization of its vision for FY2017, “Becoming a global industry leader by embracing change toward our 100th anniversary,” specifically “Achieving the world’s No. 1 position in core products.” It conducted R&D activities looking toward the medium and long term for its core products, including axles, frames, construction machinery cabs and panels. As the transition to overseas production progressed, the company also conducted research, experiments and studies on new technologies and production methods, with the aim of identifying new businesses outside its core domestic operations.」
The company continued R&D on its core products and research, experiments and studies involving new technologies and production methods. Total R&D expenses were ¥305 million. - FY2018-Q3RestatedAnnual report
「The group's total R&D expenses for the first nine months of the current consolidated cumulative period were ¥215 million. There were no material changes in the status of the group's R&D activities during the first nine months of the current consolidated cumulative period.」
The company reiterates that there were no material changes in its R&D activities, and R&D expenses were ¥215 million. - FY2018-Q2RestatedAnnual report
「The group's total R&D expenses for the first half of the current consolidated cumulative period were ¥139 million. There were no material changes in the status of the group's R&D activities during the first half of the current consolidated cumulative period.」
The company reiterates that there were no material changes in its R&D activities, and R&D expenses were ¥139 million. - FY2018-Q1RestatedAnnual report
「The group's total R&D expenses for the first quarter of the current consolidated cumulative period were ¥55 million. There were no material changes in the status of the group's R&D activities during the first quarter of the current consolidated cumulative period.」
The company reiterates that there were no material changes in its R&D activities. R&D expenses were ¥55 million. - FY2017RestatedAnnual report
「During the fiscal year, the company pursued the realization of its vision for FY2016, “Becoming a global industry leader toward our 100th anniversary,” specifically “Achieving the world’s No. 1 position in core products.” It conducted R&D activities looking toward the medium and long term for its core products, including axles, frames, construction machinery cabs and panels. As the transition to overseas production progressed, the company also conducted technical research, experiments and studies on new business initiatives, with the aim of identifying new businesses outside its core domestic operations. Total R&D expenses for the fiscal year were ¥272 million.」
While the quarterly disclosures stated that there were no material changes in R&D activities, the annual disclosure provided details of R&D on core products and technical research, experiments and studies involving new business initiatives. - FY2017-Q3RestatedAnnual report
「The group's total R&D expenses for the first nine months of the current consolidated cumulative period were ¥220 million. There were no material changes in the status of the group's R&D activities during the first nine months of the current consolidated cumulative period.」
The company reiterates that there were no material changes in its R&D activities. R&D expenses were ¥220 million. - FY2017-Q2RestatedAnnual report
「The group's total R&D expenses for the first half of the current consolidated cumulative period were ¥131 million. There were no material changes in the status of the group's R&D activities during the first half of the current consolidated cumulative period.」
The company reiterates that there were no material changes in its R&D activities. - FY2017-Q1First statedAnnual report
「The group's total R&D expenses for the first quarter of the current consolidated cumulative period were ¥57 million. There were no material changes in the status of the group's R&D activities during the first quarter of the current consolidated cumulative period.」
The company states that there were no material changes in its R&D activities and that R&D expenses for the quarter were ¥57 million.